Sign in

New Partnership to Accelerate the Fight Against Alzheimer’s Disease

Published
22 Jan 2020
2020
Share

Kirsten Salyer, Public Engagement, World Economic Forum, +41 79 265 8773, kirsten.salyer@weforum.org

  • World Economic Forum will partner over the next year with the Global CEO Initiative (CEOi) to form a Coalition to accelerate treatments for Alzheimer’s Disease
  • Without major progress, the number of people affected by the disease will triple by 2050, to 152 million people
  • The coalition will consider mechanisms to accelerate biomarker research; attract public, private and philanthropic capital; increase global capacity and performance of clinical trials; and improve the readiness of healthcare systems to detect, diagnose and treat those with Alzheimer’s
  • For more information, please visit www.weforum.org

Davos-Klosters, Switzerland, 22 January 2020 – The World Economic Forum is partnering with the Global CEO Initiative (CEOi) to form a coalition of public and private stakeholders – including pharmaceutical manufacturers, biotech companies, governments, international organizations, foundations and research agencies – to catalyse the fight against Alzheimer’s disease.

Dementia, including Alzheimer’s (a result of rapid ageing that causes dementia), is the most expensive chronic condition of the world’s growing ageing population. Dementia is the seventh leading cause of death worldwide, cost the world $1.25 trillion in 2018, and affected about 50 million people in 2019. According to the US Alzheimer’s Association, dementia is the sixth leading cause of death in the United States, and every 65 seconds, someone in the country develops the disease.

Despite many efforts from various actors and recent promising developments, the global response to the disease has not matched the scope and scale of the challenge, with no new drugs broadly to market in 15 years. Without major breakthroughs, the number of people affected will triple by 2050, to 152 million.

“Alzheimer’s disease is uniquely devastating, and there is urgent need to address the current hurdles to progress. This effort will bring together the necessary stakeholders to prioritize and resource an engaged, efficient health system and bring much-needed detection, diagnosis and treatments to those affected by the disease,” said Arnaud Bernaert, Head of Shaping the Future of Health and Health Care, World Economic Forum.

“Alzheimer’s is the biggest public health crisis of the 21st century, requiring this multi-stakeholder initiative to catalyze coordinated global action at the scope and scale of the response to AIDS, cancer and climate change,” said George Vradenburg, founder of the Global CEO Initiative on Alzheimer’s Disease and chairman and co-founder of UsAgainstAlzheimer’s.

The CEOi-WEF partnership will explore catalytic actions in four areas: pre-clinical research to advance the understanding of the disease in global cohorts, attract more capital by lowering the risks to investment in biomarkers, develop standing clinical trial platforms, and advance healthcare system readiness in the fields of detection, diagnosis, infrastructure and access. The main focus of the year ahead is to secure commitments from policymakers and business leaders through the development of a business plan that will include key activities and metrics for the coalition’s work.

About the Annual Meeting 2020:

The World Economic Forum Annual Meeting 2020 will take place on 21-24 January 2020 in Davos-Klosters, Switzerland. The meeting brings together more than 3,000 global leaders from politics, government, civil society, academia, the arts and culture as well as the media. Convening under the theme, Stakeholders for a Cohesive and Sustainable World, participants will focus on defining new models for building sustainable and inclusive societies in a plurilateral world. For further information, please click here.

About the Global CEO Initiative on Alzheimer’s Disease

The Global CEO Initiative on Alzheimer's Disease (CEOi) is an organization of private-sector leaders providing business leadership in the fight against Alzheimer's. The CEOi partners with leaders from all sectors to transform the disease from a social, health, and economic crisis into an opportunity for healthy aging through innovation in research and care. In this era of aging populations, solving the global challenge of Alzheimer's will take visionary, coordinated, goal-oriented leadership. CEOi is convened by UsAgainstAlzheimer's, an entrepreneurial, disruptive advocacy and research-focused organization that is pushing for expanding treatments and accelerating towards a cure for Alzheimer’s disease.

Notes to editors

Watch live webcasts https://wef.ch/wef20

Guide to how to follow and embed sessions on your website at http://wef.ch/howtofollow

View the best photos from the event at http://wef.ch/pics

Read the Forum Agenda at http://wef.ch/agenda

Become a fan of the Forum on Facebook at http://wef.ch/facebook

Watch Forum videos at http://wef.ch/video

Follow the Forum on Twitter via @wef and @davos, and join the conversation using #wef20 and #FairerWorld

Follow the Forum on Instagram at http://wef.ch/instagram

Follow the Forum on LinkedIn at http://wef.ch/linkedin

Learn about the Forum’s impact on http://wef.ch/impact

Subscribe to Forum news releases at http://wef.ch/news
For searchable video content from the Annual Meeting click here

The World Economic Forum, committed to improving the state of the world, is the International Organization for Public-Private Cooperation.

The Forum engages the foremost political, business and other leaders of society to shape global, regional and industry agendas. (www.weforum.org).

All opinions expressed are those of the author. The World Economic Forum Blog is an independent and neutral platform dedicated to generating debate around the key topics that shape global, regional and industry agendas.

Subscribe for updates

A weekly update of what’s on the Global Agenda

© 2021 World Economic Forum

Privacy Policy & Terms of Service